• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子A(VEGFA)通过诱导Sox2抑制微小RNA-452(miR-452),促使锌指蛋白Slug表达,从而将自我更新与转移联系起来。

VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug.

作者信息

Kim M, Jang K, Miller P, Picon-Ruiz M, Yeasky T M, El-Ashry D, Slingerland J M

机构信息

Braman Family Breast Cancer Institute at Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.

Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL, USA.

出版信息

Oncogene. 2017 Sep 7;36(36):5199-5211. doi: 10.1038/onc.2017.4. Epub 2017 May 15.

DOI:10.1038/onc.2017.4
PMID:28504716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5596211/
Abstract

Cancer stem cells (CSC) appear to have increased metastatic potential, but mechanisms underlying this are poorly defined. Here we show that VEGFA induction of Sox2 promotes EMT and tumor metastasis. In breast lines and primary cancer culture, VEGFA rapidly upregulates SOX2 expression, leading to SNAI2 induction, EMT, increased invasion and metastasis. We show Sox2 downregulates miR-452, which acts as a novel metastasis suppressor to directly target the SNAI2 3'-untranslated region (3'-UTR). VEGFA stimulates Sox2- and Slug-dependent cell invasion. VEGFA increases lung metastasis in vivo, and this is abrogated by miR-452 overexpression. Furthermore, SNAI2 transduction rescues metastasis suppression by miR-452. Thus, in addition to its angiogenic action, VEGFA upregulates Sox2 to drive stem cell expansion, together with miR-452 loss and Slug upregulation, providing a novel mechanism whereby cancer stem cells acquire metastatic potential. Prior work showed EMT transcription factor overexpression upregulates CSC. Present work indicates that stemness and metastasis are a two-way street: Sox2, a major mediator of CSC self-renewal, also governs the metastatic process.

摘要

癌症干细胞(CSC)似乎具有更强的转移潜能,但其潜在机制仍不清楚。在此我们表明,VEGFA诱导Sox2可促进上皮-间质转化(EMT)和肿瘤转移。在乳腺癌细胞系和原发性癌症培养物中,VEGFA迅速上调SOX2表达,导致SNAI2的诱导、EMT、侵袭和转移增加。我们发现Sox2下调miR-452,miR-452作为一种新型转移抑制因子直接靶向SNAI2的3'-非翻译区(3'-UTR)。VEGFA刺激Sox2和Slug依赖的细胞侵袭。VEGFA在体内增加肺转移,而miR-452过表达可消除这种作用。此外,SNAI2转导可挽救miR-452对转移的抑制作用。因此,除了其血管生成作用外,VEGFA上调Sox2以驱动干细胞扩增,同时miR-452缺失和Slug上调,为癌症干细胞获得转移潜能提供了一种新机制。先前的研究表明EMT转录因子过表达会上调CSC。目前的研究表明干性和转移是一条双向道路:Sox2作为CSC自我更新的主要调节因子,也控制着转移过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9842/5596211/1d9973c4ee01/onc20174f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9842/5596211/3eca8a50c6b9/onc20174f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9842/5596211/9cb94531c6ba/onc20174f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9842/5596211/0b602d5ad496/onc20174f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9842/5596211/ef19f9b96ed3/onc20174f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9842/5596211/5909369c7b02/onc20174f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9842/5596211/1d9973c4ee01/onc20174f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9842/5596211/3eca8a50c6b9/onc20174f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9842/5596211/9cb94531c6ba/onc20174f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9842/5596211/0b602d5ad496/onc20174f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9842/5596211/ef19f9b96ed3/onc20174f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9842/5596211/5909369c7b02/onc20174f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9842/5596211/1d9973c4ee01/onc20174f6.jpg

相似文献

1
VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug.血管内皮生长因子A(VEGFA)通过诱导Sox2抑制微小RNA-452(miR-452),促使锌指蛋白Slug表达,从而将自我更新与转移联系起来。
Oncogene. 2017 Sep 7;36(36):5199-5211. doi: 10.1038/onc.2017.4. Epub 2017 May 15.
2
VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.VEGF 通过 VEGFR-2/Stat3 信号通路驱动癌症起始干细胞,上调 Myc 和 Sox2。
Oncogene. 2015 Jun 11;34(24):3107-19. doi: 10.1038/onc.2014.257. Epub 2014 Aug 25.
3
TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1.TMPRSS4 通过 SLUG 和 TWIST1 上调 SOX2 促进前列腺癌细胞中的癌症干细胞样特性。
J Exp Clin Cancer Res. 2021 Nov 22;40(1):372. doi: 10.1186/s13046-021-02147-7.
4
microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.microRNA-33a 通过 Snail/Slug 通路抑制胃癌细胞上皮间质转化、侵袭和转移。
Am J Physiol Gastrointest Liver Physiol. 2019 Aug 1;317(2):G147-G160. doi: 10.1152/ajpgi.00284.2018. Epub 2019 Apr 3.
5
Regulation of colorectal carcinoma stemness, growth, and metastasis by an miR-200c-Sox2-negative feedback loop mechanism.miR-200c-Sox2 负反馈环路机制调控结直肠癌干细胞干性、生长和转移。
Clin Cancer Res. 2014 May 15;20(10):2631-42. doi: 10.1158/1078-0432.CCR-13-2348. Epub 2014 Mar 21.
6
Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.miR-204的抑制使口腔鳞状细胞癌能够促进癌症干性、上皮-间质转化特征和淋巴结转移。
Oncotarget. 2016 Apr 12;7(15):20180-92. doi: 10.18632/oncotarget.7745.
7
MicroRNA miR-590-5p inhibits breast cancer cell stemness and metastasis by targeting SOX2.微小RNA miR-590-5p通过靶向SOX2抑制乳腺癌细胞的干性和转移。
Eur Rev Med Pharmacol Sci. 2017 Jan;21(1):87-94.
8
The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer.SOX17/miR-371-5p/SOX2轴抑制结直肠癌中的上皮-间质转化、干细胞特性和转移。
Oncotarget. 2015 Apr 20;6(11):9099-112. doi: 10.18632/oncotarget.3603.
9
MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.微小RNA-30a通过靶向乳腺癌中的Slug增加紧密连接蛋白表达,从而抑制上皮-间质转化和转移。
Oncotarget. 2016 Mar 29;7(13):16462-78. doi: 10.18632/oncotarget.7656.
10
miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.miR-181b-3p 通过直接靶向 YWHAG 使 Snail 稳定,从而促进乳腺癌细胞的上皮-间质转化。
Biochim Biophys Acta. 2016 Jul;1863(7 Pt A):1601-11. doi: 10.1016/j.bbamcr.2016.04.016. Epub 2016 Apr 18.

引用本文的文献

1
Cinobufagin inhibits hepatocellular carcinoma EMT-like stemness via VEGF/VEGFR2 autocrine signaling.华蟾毒精通过VEGF/VEGFR2自分泌信号抑制肝细胞癌的EMT样干性。
Discov Oncol. 2025 May 26;16(1):930. doi: 10.1007/s12672-025-02707-9.
2
Ex vivo optical coherence tomography combined with near infrared targeted fluorescence: towards esophageal cancer detection.体外光学相干断层扫描结合近红外靶向荧光:用于食管癌检测
Biomed Opt Express. 2024 Sep 5;15(10):5706-5722. doi: 10.1364/BOE.537828. eCollection 2024 Oct 1.
3
Characterization of mitochondrial metabolism related molecular subtypes and immune infiltration in colorectal adenocarcinoma.

本文引用的文献

1
Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b-Mediated Malignant Progression.脂肪细胞与乳腺癌细胞之间的相互作用刺激细胞因子的产生,并驱动Src/Sox2/miR-302b 介导的恶性进展。
Cancer Res. 2016 Jan 15;76(2):491-504. doi: 10.1158/0008-5472.CAN-15-0927. Epub 2016 Jan 7.
2
High vascular endothelial growth factor gene expression predicts poor outcome in patients with non-luminal A breast cancer.高血管内皮生长因子基因表达预示非腔面A型乳腺癌患者预后不良。
Mol Clin Oncol. 2015 Sep;3(5):1103-1108. doi: 10.3892/mco.2015.574. Epub 2015 Jun 9.
3
Intratumoral heterogeneity in a Trp53-null mouse model of human breast cancer.
结直肠腺癌中线粒体代谢相关分子亚型的特征及免疫浸润分析。
Sci Rep. 2024 Oct 17;14(1):24326. doi: 10.1038/s41598-024-75482-2.
4
Non-metabolic enzyme function of pyruvate kinase M2 in breast cancer.丙酮酸激酶M2在乳腺癌中的非代谢酶功能
Front Oncol. 2024 Oct 1;14:1450325. doi: 10.3389/fonc.2024.1450325. eCollection 2024.
5
Polyoxometalate inhibition of SOX2-mediated tamoxifen resistance in breast cancer.多酸抑制 SOX2 介导的乳腺癌他莫昔芬耐药。
Cell Commun Signal. 2024 Sep 2;22(1):425. doi: 10.1186/s12964-024-01800-w.
6
A Splice Form of VEGF, a Potential Anti-Angiogenetic Form of Head and Neck Squamous Cell Cancer Inhibition.血管内皮生长因子的剪接形式,一种潜在的头颈部鳞状细胞癌抑制的抗血管生成形式。
Int J Mol Sci. 2024 Aug 14;25(16):8855. doi: 10.3390/ijms25168855.
7
EIF4A3-Induced Circ_0059914 Promoted Angiogenesis and EMT of Glioma via the miR-1249/VEGFA Pathway.EIF4A3诱导的Circ_0059914通过miR-1249/VEGFA途径促进胶质瘤的血管生成和上皮-间质转化
Mol Neurobiol. 2025 Jan;62(1):973-987. doi: 10.1007/s12035-024-04319-w. Epub 2024 Jul 1.
8
Establishing and Validating an Innovative Focal Adhesion-Linked Gene Signature for Enhanced Prognostic Assessment in Endometrial Cancer.建立和验证一个创新的黏着斑相关基因签名,用于增强子宫内膜癌的预后评估。
Reprod Sci. 2024 Aug;31(8):2468-2480. doi: 10.1007/s43032-024-01564-1. Epub 2024 Apr 23.
9
Effect of SOX2 gene on the biological characteristics of salivary adenoid cystic carcinoma cells.SOX2基因对涎腺腺样囊性癌细胞生物学特性的影响。
Hua Xi Kou Qiang Yi Xue Za Zhi. 2022 May 25;40(3):341-349. doi: 10.7518/hxkq.2022.03.015.
10
Exosomes-Promising Carriers for Regulatory Therapy in Oncology.外泌体——肿瘤调节治疗中颇具前景的载体
Cancers (Basel). 2024 Feb 25;16(5):923. doi: 10.3390/cancers16050923.
人乳腺癌Trp53基因敲除小鼠模型中的肿瘤内异质性
Cancer Discov. 2015 May;5(5):520-33. doi: 10.1158/2159-8290.CD-14-1101. Epub 2015 Mar 3.
4
VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.VEGF 通过 VEGFR-2/Stat3 信号通路驱动癌症起始干细胞,上调 Myc 和 Sox2。
Oncogene. 2015 Jun 11;34(24):3107-19. doi: 10.1038/onc.2014.257. Epub 2014 Aug 25.
5
CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis.CD44v6 是驱动结肠癌转移的组成性和重编程癌症干细胞的标志物。
Cell Stem Cell. 2014 Mar 6;14(3):342-56. doi: 10.1016/j.stem.2014.01.009.
6
Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures.原发性乳腺肿瘤来源的细胞模型:解离肿瘤(DT)培养物中致瘤性、转移性和癌症相关成纤维细胞的特征
Breast Cancer Res Treat. 2014 Apr;144(3):503-17. doi: 10.1007/s10549-014-2887-9. Epub 2014 Feb 25.
7
VEGF targets the tumour cell.VEGF 靶向肿瘤细胞。
Nat Rev Cancer. 2013 Dec;13(12):871-82. doi: 10.1038/nrc3627.
8
Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells.蛋白激酶 Cα 是乳腺癌干细胞的核心信号节点和治疗靶点。
Cancer Cell. 2013 Sep 9;24(3):347-64. doi: 10.1016/j.ccr.2013.08.005.
9
Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ-secretase inhibitor drug responses.三阴性乳腺癌起始细胞亚群在功能和分子特征以及 γ-分泌酶抑制剂药物反应方面存在差异。
EMBO Mol Med. 2013 Oct;5(10):1502-22. doi: 10.1002/emmm.201302558. Epub 2013 Aug 27.
10
A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer.基于基因表达的生物标志物预测乳腺癌他莫昔芬治疗后结局的荟萃分析。
Breast Cancer Res Treat. 2013 Jul;140(2):219-32. doi: 10.1007/s10549-013-2622-y. Epub 2013 Jul 9.